Entering the Era of Molecular-Targeted Precision Surgery in Recurrent Prostate Cancer

Journal of Nuclear Medicine - China
doi 10.2967/jnumed.118.221861
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Society of Nuclear Medicine

Related search

Percent Free Prostate-Specific Antigen: Entering a New Era in the Detection of Prostate Cancer

Mayo Clinic Proceedings
Medicine
1997English

Entering a New Era – Prostate Cancer Immuno-Therapy After the FDA Approval for Sipuleucel-T

2011English

Prostate Cancer Stem Cells: Molecular Characterization for Targeted Therapy

Asian Journal of Andrology
MedicineUrology
2012English

Cancer Surgery in the Genomic Era

British Journal of Surgery
Surgery
2018English

Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2014English

Surgery in Recurrent Ovarian Cancer

Cancer
Cancer ResearchOncology
2019English

Managing Localized Prostate Cancer in the Era of Prostate-Specific Antigen Screening

Cancer
Cancer ResearchOncology
2013English

Targeted Molecular-Genetic Imaging and Ligand-Directed Therapy in Aggressive Variant Prostate Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2016English

Surgery for Recurrent Uterine Cancer

International Journal of Gynecological Cancer
GynecologyOncologyObstetrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy